265 related articles for article (PubMed ID: 29530082)
1. The role of gender relations in uptake of mass drug administration for lymphatic filariasis in Alor District, Indonesia.
Krentel A; Wellings K
Parasit Vectors; 2018 Mar; 11(1):179. PubMed ID: 29530082
[TBL] [Abstract][Full Text] [Related]
2. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
[TBL] [Abstract][Full Text] [Related]
3. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
[TBL] [Abstract][Full Text] [Related]
4. Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts/cities of Indonesia.
Titaley CR; Damayanti R; Soeharno N; Mu'asyaroh A; Bradley M; Lynam T; Krentel A
Parasit Vectors; 2018 May; 11(1):315. PubMed ID: 29801511
[TBL] [Abstract][Full Text] [Related]
5. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
[TBL] [Abstract][Full Text] [Related]
6. Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.
Ahorlu CSK; Koka E; Adu-Amankwah S; Otchere J; de Souza DK
BMC Public Health; 2018 Feb; 18(1):238. PubMed ID: 29433461
[TBL] [Abstract][Full Text] [Related]
7. How community engagement strategies shape participation in mass drug administration programmes for lymphatic filariasis: The case of Luangwa District, Zambia.
Silumbwe A; Halwindi H; Zulu JM
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007861. PubMed ID: 31774820
[TBL] [Abstract][Full Text] [Related]
8. Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana.
Manyeh AK; Ibisomi L; Ramaswamy R; Baiden F; Chirwa T
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0007009. PubMed ID: 32804967
[TBL] [Abstract][Full Text] [Related]
9. The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.
Njomo DW; Amuyunzu-Nyamongo M; Magambo JK; Njenga SM
PLoS One; 2012; 7(11):e48395. PubMed ID: 23185256
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar.
Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Wood P; Wangdi K; McBride WJ
Parasit Vectors; 2021 Jan; 14(1):72. PubMed ID: 33482891
[TBL] [Abstract][Full Text] [Related]
11. Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
de Souza DK; Gass K; Otchere J; Htet YM; Asiedu O; Marfo B; Biritwum NK; Boakye DA; Ahorlu CS
PLoS Negl Trop Dis; 2020 May; 14(5):e0008306. PubMed ID: 32407319
[TBL] [Abstract][Full Text] [Related]
12. Awareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.
Adhikari RK; Sherchand JB; Mishra SR; Ranabhat K; Wagle RR
J Community Health; 2015 Feb; 40(1):34-40. PubMed ID: 24996654
[TBL] [Abstract][Full Text] [Related]
13. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance.
Babu BV; Mishra S
Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1207-13. PubMed ID: 18632125
[TBL] [Abstract][Full Text] [Related]
14. Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008.
Cantey PT; Rao G; Rout J; Fox LM
Trop Med Int Health; 2010 Feb; 15(2):224-31. PubMed ID: 20002615
[TBL] [Abstract][Full Text] [Related]
15. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
Lahariya C; Mishra A
J Vector Borne Dis; 2008 Dec; 45(4):313-20. PubMed ID: 19248659
[TBL] [Abstract][Full Text] [Related]
16. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.
Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA
Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788
[TBL] [Abstract][Full Text] [Related]
17. Causal chain mapping: a novel method to analyse treatment compliance decisions relating to lymphatic filariasis elimination in Alor, Indonesia.
Krentel A; Aunger R
Health Policy Plan; 2012 Aug; 27(5):384-95. PubMed ID: 21712348
[TBL] [Abstract][Full Text] [Related]
18. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
[TBL] [Abstract][Full Text] [Related]
19. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Nandha B; Krishnamoorthy K; Jambulingam P
Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
[TBL] [Abstract][Full Text] [Related]
20. Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis.
Maroto-Camino C; Hernandez-Pastor P; Awaca N; Safari L; Hemingway J; Massangaie M; Whitson D; Jeffery C; Valadez JJ
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007337. PubMed ID: 31276494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
